Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
JHLT Open|March 27, 2025
Corticosteroid use beyond 1-year post heart transplantation is associated with worse outcomes: A contemporary analysis of the ISHLT registryAbhishek Jaiswal, William L Baker, Ashwin Pillai, et al.JAMA Cardiology|June 10, 2026
Cost Offset With Quadruple Therapy for Heart FailureMohammad Keykhaei, Sina Rashedi, Stephen J Greene, et al.Interactive Cardiovascular and Thoracic Surgery|July 9, 2018
Dual-organ transplantation in older recipients: outcomes after heart-kidney transplant versus isolated heart transplant in patients aged ≥65 yearsHeidi Reich, Sadia Dimbil, Ryan Levine, et al.Journal of Interventional Cardiology|October 15, 2013
Clinical and angiographic outcomes with everolimus eluting stents for the treatment of cardiac allograft vasculopathyBabak Azarbal, Boris Arbit, Radhakrishnan Ramaraj, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 23, 2011
Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantationBabak Azarbal, Paul Poommipanit, Boris Arbit, et al.Journal of Cardiac Failure|June 19, 2022
Vaccines, Antibodies and Donors: Varying Attitudes and Policies Surrounding COVID-19 and Heart TransplantationErsilia M Defilippis, Larry A Allen, Ankeet S Bhatt, et al.Circulation. Cardiovascular Quality and Outcomes|December 11, 2020
A Blueprint for Productive Maintenance of Certification, But Is the American Board of Internal Medicine up to the Challenge?Daniel Alyesh, Alok Gambhir, Marc Waase, et al.Circulation. Heart Failure|February 21, 2015
Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trialJon Kobashigawa, Jignesh Patel, Babak Azarbal, et al.Journal of the American College of Cardiology|June 12, 2003
Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortalityMichelle Kittleson, Shelley Hurwitz, Monica R Shah, et al.Journal of Clinical Medicine|September 13, 2025
The Total Artificial Heart: A Historical PerspectiveDaniele Masarone, Rita Gravino, Luigi Falco, et al.Pageof 9